跳至主要内容
临床试验/CTRI/2024/04/065927
CTRI/2024/04/065927已完成Phase 3 4

Effect of topical application of bilwadi agada followed by nalpamaradi taila in dadru wsr to tinea corporis: an open labelled clinical trial

Dr Sushma Ghoolappa Kanavi1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年5月1日最近更新:

试验速览

阶段
Phase 3 4
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
primary outcome- decrease in fungal load from 0th day to 21st day

研究概览

简要总结

Dermatophyte is a common label for a group of fungus of Arthrodermataceae family that commonly causes skin infection in humans and animals. Fungal skin infection can be superficial or less commonly deep; the latter are seen more often in tropical climates or in the immunocompromised. Dermatophyte infections are extremely common and usually caused by the fungi of the Microsporum, Trichophyton and Epidermophyton species. The fungi can originate from soil(geophilic) or animals(zoophilic) or be confined to human skin(anthropophilic).

TINEA CORPORIS

The site of infection is typically on exposed skin unless the infection represents an extension of a pre-existing infection. In such cases, infection may spread from the scalp, down the neck onto the upper trunk, or from the groins onto the buttocks and lower trunk. Characteristics lesions are circular, usually sharply emarginated with a raised edge. Single lesions occur or there may be multiple plaques. The latter may remain discrete or become concrescent. The degree of inflammation is roughly proportional to the extent of follicular invasion, thus tinea corporis is generally less inflammatory than tinea capitis or tinea barbae. In quieter infections scaling is common but not a constant finding. Sometimes pustules or vesicles may dominate. Central resolution in the lesions may occur but not an invariable feature of tinea corporis.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient diagnosed with Tinea corporis Patients aged between 18 to 60 years Irrespective of sex Positive mycological findings of less than 30 Percentage of the body surface involvement will be recruited for the study.

排除标准

  • Patients undergoing antifungal treatment Generalized skin conditions such as herpes zoster urticaria pemphigus and psoriasis Patient with Diabetes mellitus and uncontrolled hypertension Systemic diseases RA Liver and renal dysfunction Patient with the treatment of phototherapy and corticosteroids Hypersensitive patients.

结局指标

主要结局

primary outcome- decrease in fungal load from 0th day to 21st day

时间窗: 0th 11th and 21st day

次要结局

  • KANDU Itching(RAGA Erythema)

研究者

发起方
Dr Sushma Ghoolappa Kanavi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sushma Ghoolappa Kanavi

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya Shahapur Belagavi

研究点 (1)

Loading locations...

相似试验